ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 297,03
0,91%
DAX
19 848,77
-0,34%
Brent Oil
73,285
0,00%
Bitcoin
98 025,43
-0,68%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV

  6. Theralase Technologies Inc (TLT) Cours

Theralase Technologies Inc

Theralase Technologies Inc (TLT)

Tilt Renewables Limited
The London Tunnels PLC
iShares 20+ Year Treasury Bond ETF
iShares 20 plus Year Treasury Bond
0,26
0,015
(6,12%)
Fermé 25 Décembre 10:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,26
Prix Achat
0,24
Prix Vente
0,26
Volume échangé
17 500
0,24 Fourchette du Jour 0,26
0,14 Plage de 52 semaines 0,38
Cap du marché
59,4M
Clôture Veille
0,245
Ouverture
0,245
Dernière Transaction
1000
@
0.26
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
128 747
Actions en circulation
228 460 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-13,00
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess
1,07M
Bénéfice net
-4,57M

À propos de Theralase Technologies Inc

Secteur
Electromedical Apparatus
Industrie
Electromedical Apparatus
Site Web
www.theralase.com
Siège social
Toronto, Ontario, Can
Fondé
-
Theralase Technologies Inc est coté dans le secteur Electromedical Apparatus de la TSX Venture Exchange avec le ticker TLT. Le dernier cours de clôture d'Theralase Technologies était de $0,25. Au cours de la dernière année, les actions de Theralase Technologies ont été négociées dans une fourchette de prix de $ 0,14 à $ 0,38.

Theralase Technologies compte actuellement 228 460 000 actions en circulation. La capitalisation boursière d'Theralase Technologies est de $55,97 million. Theralase Technologies a un ratio cours/bénéfice (ratio PE) de -13.00.

TLT Dernières nouvelles

Plus de nouvelles

Theralase® Releases FY2022 Audited Financial Statements

TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the...

27 Avril 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium

TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

23 Février 2023
GlobeNewswire Inc.

Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company

TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

21 Février 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the AUA Annual Meeting

TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

02 Février 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium

TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

25 Janvier 2023
GlobeNewswire Inc.

Theralase ® Announces Warrant Extension

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...

06 Janvier 2023
GlobeNewswire Inc.

Theralase Releases Q322 Interim Financial Statements

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the...

30 Novembre 2022
GlobeNewswire Inc.

Theralase® Grants Stock Options

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

21 Novembre 2022
GlobeNewswire Inc.

Theralase ® Closes Private Placement Equity Financing

TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

17 Novembre 2022
GlobeNewswire Inc.

Theralase® Commences $CAN 2.5 M Follow-On Private Placement Equity Financing

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”...

03 Octobre 2022
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.260.280.23979620.25408537CS
4-0.02-7.142857142860.280.30.21243310.23922488CS
120.0952.94117647060.170.380.171287470.28246062CS
260.0736.84210526320.190.380.16946970.24452036CS
520.09557.57575757580.1650.380.141158130.20773487CS
156-0.075-22.38805970150.3350.480.141164260.27780651CS
260-0.07-21.21212121210.330.480.121897990.24499024CS

TLT - Frequently Asked Questions (FAQ)

What is the current Theralase Technologies share price?
The current share price of Theralase Technologies is $ 0,26
How many Theralase Technologies shares are in issue?
Theralase Technologies has 228 460 000 shares in issue
What is the market cap of Theralase Technologies?
The market capitalisation of Theralase Technologies is CAD 55,97M
What is the 1 year trading range for Theralase Technologies share price?
Theralase Technologies has traded in the range of $ 0,14 to $ 0,38 during the past year
What is the PE ratio of Theralase Technologies?
The price to earnings ratio of Theralase Technologies is -13
What is the cash to sales ratio of Theralase Technologies?
The cash to sales ratio of Theralase Technologies is 55,32
What is the reporting currency for Theralase Technologies?
Theralase Technologies reports financial results in CAD
What is the latest annual turnover for Theralase Technologies?
The latest annual turnover of Theralase Technologies is CAD 1,07M
What is the latest annual profit for Theralase Technologies?
The latest annual profit of Theralase Technologies is CAD -4,57M
What is the registered address of Theralase Technologies?
The registered address for Theralase Technologies is 41 HOLLINGER ROAD, TORONTO, ONTARIO, M4B 3G4
What is the Theralase Technologies website address?
The website address for Theralase Technologies is www.theralase.com
Which industry sector does Theralase Technologies operate in?
Theralase Technologies operates in the ELECTROMEDICAL APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CANSWildpack Beverage Inc
$ 0,01
(100,00%)
2,12M
SQGSpackman Equities Group Inc
$ 4,26
(70,40%)
48,12k
PWROPower One Resources Corp
$ 0,025
(66,67%)
31k
NZPChatham Rock Phosphate Limited
$ 0,08
(60,00%)
2,2k
ADDArctic Star Exploration Corp
$ 0,015
(50,00%)
2k
TVITVI Pacific Inc
$ 0,005
(-50,00%)
2k
CCDCascadero Copper Corporation
$ 0,005
(-50,00%)
1,56k
KGL.HKGL Resources Ltd
$ 0,03
(-40,00%)
5,5k
SAFSeasif Exploration Inc
$ 0,025
(-37,50%)
61k
AAZAzincourt Energy Corp
$ 0,01
(-33,33%)
110,54k
CPLCopper Lake Resources Ltd
$ 0,01
(0,00%)
11,98M
WCUWorld Copper Ltd
$ 0,05
(-23,08%)
5,75M
QNCQuantum Emotion Corp
$ 0,66
(24,53%)
4,89M
THRMTherma Bright Inc
$ 0,035
(16,67%)
2,64M
CANSWildpack Beverage Inc
$ 0,01
(100,00%)
2,12M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSXV
TLT
Theralase Technologies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés